{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:16:41Z","timestamp":1772795801463,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019717","name":"AstraZeneca Pharmaceutical Spain","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Patient Education and Counseling"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.pec.2025.109289","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T22:56:00Z","timestamp":1754434560000},"page":"109289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Do patients with HER2+ MBC and their HCPs speak the same language? Perceptions and uses of chronic disease and metastatic treatment arising from the EtnobreastHER2 study"],"prefix":"10.1016","volume":"140","author":[{"given":"Joaqu\u00edn","family":"Gavil\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Rodr\u00edguez-Lescure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Antol\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Cantos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"\u00c1ngel Segu\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Antonia Gim\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fcl","family":"Rubio Renau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlota","family":"Sol\u00e0 Marsi\u00f1ach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Mart\u00edn Ill\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo Fonseca","family":"Vallejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaiza Gimeno","family":"Guadalupe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noelia","family":"Alfaro Oliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6880-0301","authenticated-orcid":false,"given":"Jos\u00e9 \u00c1ngel","family":"Garc\u00eda-S\u00e1enz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pec.2025.109289_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40644-023-00608-0","article-title":"Pretreatment 18F-FDG uptake heterogeneity May predict treatment outcome of combined trastuzumab and pertuzumab therapy in patients with metastatic HER2 positive breast cancer","volume":"23","author":"Ma","year":"2023","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.pec.2025.109289_bib2","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.pec.2025.109289_bib3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10549-020-05577-7","article-title":"Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane\/trastuzumab in patients with previously treated, unresectable, or metastatic HER2-positive breast cancer: a systematic review and network meta-analysis","volume":"180","author":"Paracha","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.pec.2025.109289_bib4","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1200\/JCO.20.01204","article-title":"Adjuvant pertuzumab and trastuzumab in early HER2-Positive breast cancer in the APHINITY trial: 6 Years\u2019 Follow-Up","volume":"39","author":"Piccart","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pec.2025.109289_bib5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12967-018-1460-4","article-title":"Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer","volume":"16","author":"Takada","year":"2018","journal-title":"J Transl Med"},{"key":"10.1016\/j.pec.2025.109289_bib6","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S1470-2045(08)70177-3","article-title":"Part II: milestones in personalised Medicine\u2014trastuzumab","volume":"9","author":"Gelmon","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pec.2025.109289_bib7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/1049732313483926","article-title":"Communication challenges for chronic metastatic cancer in an era of novel therapeutics","volume":"23","author":"Thorne","year":"2013","journal-title":"Qual Health Res"},{"key":"10.1016\/j.pec.2025.109289_bib8","article-title":"Exploring the concepts and practices of advanced breast cancer treatment: a narrative review","volume":"9","author":"Wang","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.pec.2025.109289_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/13648470.2022.2041547","article-title":"The nebula of chronicity: dealing with metastatic breast cancer in the UK","volume":"29","author":"Greco","year":"2022","journal-title":"Anthr Med"},{"key":"10.1016\/j.pec.2025.109289_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2016.00159","article-title":"Use your words carefully: what is a chronic disease?","volume":"4","author":"Bernell","year":"2016","journal-title":"Front Public Health"},{"key":"10.1016\/j.pec.2025.109289_bib11","article-title":"Tendencia de los principales factores de riesgo de enfermedades cr\u00f3nicas","author":"Guti\u00e9rrez-Fisac","year":"2013","journal-title":"Espa\u00f1a 20012011\/12"},{"key":"10.1016\/j.pec.2025.109289_bib12","author":"WHO","year":"2016","journal-title":"Noncommunicable Dis"},{"key":"10.1016\/j.pec.2025.109289_bib13","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1177\/1049732315591787","article-title":"Living well? Strategies used by women living with metastatic breast cancer","volume":"26","author":"Lewis","year":"2016","journal-title":"Qual Health Res"},{"key":"10.1016\/j.pec.2025.109289_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/HNP.0000000000000316","article-title":"Metastatic breast cancer as a chronic condition: holistic care considerations","volume":"33","author":"Zuzelo","year":"2019","journal-title":"Holist Nurs Pr"},{"key":"10.1016\/j.pec.2025.109289_bib15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.clbc.2021.06.012","article-title":"Can women with HER2-Positive metastatic breast cancer be cured?","volume":"21","author":"Haji","year":"2021","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.pec.2025.109289_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000502636","article-title":"Metastatic breast cancer as a chronic disease: evidence-Based data on a theoretical concept","volume":"15","author":"Elfgen","year":"2020","journal-title":"Breast Care"},{"key":"10.1016\/j.pec.2025.109289_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-anthro-092010-153345","article-title":"Phenomenological approaches in anthropology","volume":"40","author":"Desjarlais","year":"2011","journal-title":"Annu Rev Anthr"},{"key":"10.1016\/j.pec.2025.109289_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11017-010-9161-x","article-title":"Phenomenology and its application in medicine","volume":"32","author":"Carel","year":"2011","journal-title":"Theor Med Bioeth"},{"key":"10.1016\/j.pec.2025.109289_bib19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1466-769X.2011.00532.x","article-title":"Abductive reasoning and qualitative research: abductive reasoning","volume":"13","author":"Lipscomb","year":"2012","journal-title":"Nurs Philos"},{"key":"10.1016\/j.pec.2025.109289_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2021.114523","article-title":"Sample sizes for saturation in qualitative research: a systematic review of empirical tests","volume":"292","author":"Hennink","year":"2022","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.pec.2025.109289_bib21","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","article-title":"Saturation in qualitative research: exploring its conceptualization and operationalization","volume":"52","author":"Saunders","year":"2018","journal-title":"Qual Quant"},{"key":"10.1016\/j.pec.2025.109289_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232076","article-title":"A simple method to assess and report thematic saturation in qualitative research","volume":"15","author":"Guest","year":"2020","journal-title":"PLOS ONE"},{"key":"10.1016\/j.pec.2025.109289_bib23","first-page":"875","article-title":"Theoretical saturation","volume":"2","author":"Sandelowski","year":"2008"},{"key":"10.1016\/j.pec.2025.109289_bib24","first-page":"7","article-title":"MUSINGS OF a CANCER DOCTOR: chronic","volume":"36","author":"Sledge","year":"2014","journal-title":"Oncol"},{"key":"10.1016\/j.pec.2025.109289_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.currproblcancer.2016.09.005","article-title":"Metastatic human epidermal growth factor receptor 2-positive breast cancer: management, challenges, and future directions","volume":"40","author":"Soleja","year":"2016","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.pec.2025.109289_bib26","doi-asserted-by":"crossref","first-page":"v25","DOI":"10.1093\/annonc\/mdn305","article-title":"Long-term survivorship after cancer: how far have we come?","volume":"19","author":"Foss\u00e5","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pec.2025.109289_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/jpm.2018.0127","article-title":"The experience of being aware of disease status in women with recurrent ovarian cancer: a phenomenological study","volume":"22","author":"Finlayson","year":"2019","journal-title":"J Palliat Med"},{"key":"10.1016\/j.pec.2025.109289_bib28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/09581596.2022.2035319","article-title":"Chronicity in\/and cancer: a qualitative interview study of health professionals, patients, and family carers","volume":"32","author":"Kirby","year":"2022","journal-title":"Crit Public Health"},{"key":"10.1016\/j.pec.2025.109289_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2016.1861","article-title":"Determinants of Patient-Oncologist prognostic discordance in advanced cancer","author":"Gramling","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.pec.2025.109289_bib30","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1634\/theoncologist.2018-0890","article-title":"Beliefs about advanced cancer curability in older patients, their caregivers, and oncologists","volume":"24","author":"Loh","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.pec.2025.109289_bib31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/pon.4467","article-title":"Patients\u2019 and family caregivers\u2019 understanding of the cancer stage, treatment goal, and chance of cure: a study with patient-caregiver-physician triad","volume":"27","author":"Shin","year":"2018","journal-title":"Psychooncology"},{"key":"10.1016\/j.pec.2025.109289_bib32","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.3390\/healthcare11152222","article-title":"Clinicians\u2019 and advanced cancer Patients\u2019 estimates of treatment efficacy and toxicity in oncologic treatment","volume":"11","author":"Lee","year":"2023","journal-title":"Healthcare"},{"key":"10.1016\/j.pec.2025.109289_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.0018","article-title":"Association of prognostic understanding with health care use among older adults with advanced cancer: a secondary analysis of a cluster randomized clinical trial","volume":"5","author":"Loh","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.pec.2025.109289_bib34","article-title":"Prognostic disclosure in cancer care: a systematic literature review","volume":"16","author":"Sutar","year":"2022","journal-title":"Palliat Care Soc Pr"},{"key":"10.1016\/j.pec.2025.109289_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6939-5-7","article-title":"Disclosure of cancer diagnosis and prognosis: a survey of the general public\u2019s attitudes toward doctors and family holding discretionary powers","volume":"5","author":"Miyata","year":"2004","journal-title":"BMC Med Ethics"},{"key":"10.1016\/j.pec.2025.109289_bib36","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/pon.918","article-title":"Family centred decision making and non-disclosure of diagnosis in a south east asian oncology practice","volume":"14","author":"Back","year":"2005","journal-title":"Psychooncology"},{"key":"10.1016\/j.pec.2025.109289_bib37","series-title":"Serious illness conversation guide","author":"Ariadne Labs and Dana-Farber Cancer Institute","year":"2015"},{"key":"10.1016\/j.pec.2025.109289_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.pec.2024.108331","article-title":"What influences provision of information about recovery on stroke units? A focused ethnographic case study","volume":"126","author":"Burton","year":"2024","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.pec.2025.109289_bib39","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.3390\/healthcare11192611","article-title":"Palliative care survey: awareness, knowledge and views of the styrian population in Austria","volume":"11","author":"Spary-Kainz","year":"2023","journal-title":"Healthcare"},{"key":"10.1016\/j.pec.2025.109289_bib40","unstructured":"Science Medicines Health. EMA medical terms simplifier. Plain-language description of medical terms related to medicines use 2022."},{"key":"10.1016\/j.pec.2025.109289_bib41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1179\/096992610X12624290276421","article-title":"Language, discourse and meaning in palliative Medicine","volume":"18","author":"O\u2019Connor","year":"2010","journal-title":"Prog Palliat Care"},{"key":"10.1016\/j.pec.2025.109289_bib42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1191\/0269216306pm1156oa","article-title":"Would you like to talk about your future treatment options?\u2019 discussing the transition from curative cancer treatment to palliative care","volume":"20","author":"Schofield","year":"2006","journal-title":"Palliat Med"},{"key":"10.1016\/j.pec.2025.109289_bib43","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/jme.2006.018895","article-title":"From cure to palliation: concept, decision and acceptance","volume":"33","author":"Lofmark","year":"2007","journal-title":"J Med Ethics"},{"key":"10.1016\/j.pec.2025.109289_bib44","first-page":"356","article-title":"Improving patient and caregiver outcomes in oncology: team-based, timely, and targeted palliative care","volume":"68","author":"Hui","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.pec.2025.109289_bib45","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/bmjspcare-2012-000200","article-title":"Defining chronic cancer: patient experiences and self-management needs","volume":"2","author":"Harley","year":"2012","journal-title":"BMJ Support Palliat Care"}],"container-title":["Patient Education and Counseling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738399125006561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738399125006561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:24:14Z","timestamp":1772789054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738399125006561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":45,"alternative-id":["S0738399125006561"],"URL":"https:\/\/doi.org\/10.1016\/j.pec.2025.109289","relation":{},"ISSN":["0738-3991"],"issn-type":[{"value":"0738-3991","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do patients with HER2+ MBC and their HCPs speak the same language? Perceptions and uses of chronic disease and metastatic treatment arising from the EtnobreastHER2 study","name":"articletitle","label":"Article Title"},{"value":"Patient Education and Counseling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pec.2025.109289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109289"}}